首页 | 官方网站   微博 | 高级检索  
     

格列美脲与阿卡波糖治疗2型糖尿病60例观察
引用本文:李德高.格列美脲与阿卡波糖治疗2型糖尿病60例观察[J].中国医疗前沿,2013(12):36-37.
作者姓名:李德高
作者单位:广西贺州市昭平县中医医院内分泌科 ,546800
摘    要:目的观察格列美脲与阿卡波糖治疗2型糖尿病(T2DM)的临床疗效。方法选取T2DM患者60例,予以格列美脲与阿卡波糖口服12周。结果治疗后TG(甘油三酯)、TC(总胆固醇)、LDL-C(低密度脂蛋白)、FPG(空腹血糖)、2hPG(餐后2h血糖)、HbA1c(糖化血红蛋白)均下降(P〈0.05),HDL-C(高密度脂蛋白)升高(P〈0.05),HOMA-IR(胰岛素抵抗指数)改善(P〈0.05)。结论格列美脲联合阿卡波糖治疗T2DM,血糖控制满意,血脂、HOMA-IR改善。

关 键 词:格列美脲  阿卡波糖  2型糖尿病

To observe glimepiride and acarbose treatment on 60 cases with type 2 diabetes meUitus
LI De-gao.To observe glimepiride and acarbose treatment on 60 cases with type 2 diabetes meUitus[J].China Healthcare Innovation,2013(12):36-37.
Authors:LI De-gao
Affiliation:LI De-gao. Traditional Chinese Medicine Hospital of Zhaoping County, Hezhou 546800, China
Abstract:Objective To observe glimepiride and acarbose treatment on 60 cases with type 2 diabetes mellitus(T2DM). Method Glimepiride and acarbose were used 12 weeks in 60 patients with T2DM. Results TG,TC, LDL-C, FBG, 2hPG and HbAlc decreased while HDLJC incressed after treatment(P〈0.05); HOMA-IR was improved more significantly(P〈0.05). Conclusion Glimepiride and acarbose to treat T2DM have satisfactory effects in glucose, blood lipids and HOMA-IR.
Keywords:T2DM  Glimepiride  Acarbose
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号